AzTrials
AzTrials

SurgeryNCT07641153

VR-Based Cognitive Stimulation Games for Delirium Prevention

A study testing Virtual Reality Software and Virtual Reality movies in people with Surgery and Delirium - Postoperative, run by The Methodist Hospital Research Institute at 2 sites in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This trial aims to evaluate the feasibility, safety, and acceptability of a virtual reality (VR)-based cognitive stimulation game to reduce postoperative delirium among older surgical patients at high risk due to pre-existing cognitive impairment. Read more about this study

Who is it for?
Ages Up to 65 years
Conditions the study is for
Surgery, Delirium - Postoperative, Delirium
What is being tested?
Virtual Reality Software and Virtual Reality movies
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
2 sitesUnited States
Study dates
24 Apr 2026to 1 May 2029
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 65 years
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Men and women ≥65 years of age
  • Have a pre-existing diagnosis of cognitive impairment (Montreal Cognitive Assessment Score of 15-24)
  • Elective or emergency major surgery with the expectation of admission to the Intensive Care Unit following the surgery for three days following surgery

Who cannot join

  • Pre-existing Intubation and invasive ventilation;
  • history of severe mental illness;
  • admission for a drug overdose;
  • severe vertigo;
  • history of severe postoperative nausea and vomiting;
  • hearing and visual impairment;
Show all 10Show fewer
  • preexisting severe dementia (Montreal Cognitive Assessment Score < 15; and
  • active delirium at the time of screening for eligibility criteria.
  • Active suicidal ideation or behavior Screen failure after surgery
  • Prolonged intubation after surgery (more than 24 hours)

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

United States2 sites, 2 recruiting
  • Houston Methodist Hospital

    Houston, Texas, 77030

    Hina Faisal, MD, 713-448-0343, hfaisal@houstonmethodist.org

    Recruiting
  • Houston Methodist Research Insititute

    Houston, Texas, 77030

    Hina Faisal, MD

    Recruiting

Other trials in United States

About this study

Official title: Virtual Reality-Based Cognitive Stimulation Games for Enhancing Attention and Preventing Delirium in Older Surgical Patients With Cognitive Impairment

This trial aims to evaluate the feasibility, safety, and acceptability of a virtual reality (VR)-based cognitive stimulation game to reduce postoperative delirium among older surgical patients at high risk due to pre-existing cognitive impairment.

Read the detailed description

Delirium is a sudden, fluctuating disturbance in consciousness and cognition and is highly prevalent in older surgical patients. Delirium is preventable; non-pharmacological interventions, such as cognitive stimulation (CS), are the best preventive strategies. Implementing CS in acute hospital settings is a significant challenge due to limited resources and low patient engagement. Virtual reality (VR) and gamification for CS delivery could be a scalable, engaging solution. Based on my preliminary work, I hypothesize that VR- based CS games will be safe, feasible, and acceptable in high-risk older patients (Aim 1). The proposed study will estimate the intervention's effect on cognitive functions, particularly sustained attention (Aim 2), and the incidence of postoperative delirium (Aim 3). To accomplish the above goals, I will conduct a randomized controlled pilot trial involving 90 patients ≥65 years old with pre-existing cognitive impairment admitted to the hospital following a major surgery. Patients will be randomized 1:1:1 to receive VR-based CS games (intervention), watch a VR movie (VR control), or receive standard-of-care nurse-led reality orientation (Nurse control). The trial will provide me with preliminary data to support an R01 application.

Being tested
Virtual Reality Software, Virtual Reality movies, Nurse led control arm
Medical subject headings
Emergence Delirium, Delirium

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Virtual Reality SoftwareOther

    The ReCognition virtual reality (VR) software is delivered via an Oculus Quest 2 device. This three-dimensional simulated software was designed to improve attention and executive functions. The VR session will occur once per day for 20 minutes.

  • Virtual Reality moviesOther

    This virtual reality software is delivered via an Oculus Quest 2 device. The Oculus Quest 2 device will be used to watch an educational movie. The VR session will occur once per day for 20 minutes.

  • Nurse led control armOther

    Reality orientation therapy focused on time, place, and person, administered twice daily, typically at the beginning and end of nursing shifts.

Study groups in NCT07641153
Study groupRoleWhat they receive
VR intervention: VR-based cognitive stimulation gamesExperimentalParticipants will engage in interactive, VR-based cognitive stimulation games.
Receives: Other: Virtual Reality Software
VR Control: watching a movie in VRExperimentalParticipants will watch a non-interactive VR movie experience consisting of educational material.
Receives: Other: Virtual Reality movies
Nurse control: standard-of-care nurse-led reality orientationExperimentalParticipants will receive standard-of-care, nurse-led reality orientation therapy.
Receives: Other: Nurse led control arm

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility of the trial and VR-based cognitive stimulation intervention

    A composite of recruitment rate, outcomes data completion, usability of VR intervention, acceptance of the VR intervention, and adherence to VR sessions

    Measured: At Postoperative day 7 or Hospital discharge (whichever comes first)

  2. Adherence of VR-based cognitive stimulation intervention

    Number screened, consented, enrolled, and administered VR

    Measured: Baseline to Postoperative day 7 or Hospital discharge (whichever comes first)

  3. Safety of VR-based cognitive stimulation intervention

    adverse event

    Measured: Postoperative day 1 -3

  4. Acceptability of VR-based cognitive stimulation intervention

    Behavioral intention scale score

    Measured: At Postoperative day 7 or Hospital discharge (whichever comes first)

  5. Usability of VR-based cognitive stimulation intervention

    System usability scale score

    Measured: At Postoperative day 7 or Hospital discharge (whichever comes first)

Secondary outcomes (5)
  1. Months backward test, pre-intervention

    Measurement of attention and working memory (Cognitive outcome)

    Measured: At Post operative day 1

  2. Months backward test, post-intervention

    Measurement of attention and working memory

    Measured: At Post-operative Day 3

  3. NIH Flanker test, pre-intervention

    Measurement of attention and working memory (Cognitive outcome)

    Measured: At Post operative day 1

  4. NIH Flanker test, post-intervention

    Measurement of attention and working memory (Cognitive outcome)

    Measured: At Post operative day 3

  5. VR games performances

    Measurement of attention and working memory (Cognitive outcome)

    Measured: At Postoperative day 1, 2 and 3

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jun 2026
  2. Study start24 Apr 2026
  3. Primary completion1 May 2029 (estimated)
  4. Study completion1 May 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
90 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07641153
Sponsor's protocol ID
Pro00041199
Other IDs
1K76AG088424-01A1
Status last verified
Jun 2026
First submitted
2 Jun 2026
Last updated
11 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Virtual Reality Software and Virtual Reality movies in people with Surgery and Delirium - Postoperative, run by The Methodist Hospital Research Institute at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 11 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Hina Faisal, MD (346-356-1400, hfaisal@houstonmethodist.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility of the trial and VR-based cognitive stimulation intervention (time frame: At Postoperative day 7 or Hospital discharge (whichever comes first)). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jun 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in